XML 109 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue Recognition (Tables)
 12 Months Ended
Dec. 31, 2019
Revenue from External Customer [Line Items]  
Contract with customer balances
The following table provides information about contract assets from contracts with customers (in millions):
 
Balance Sheet Location
 
December 31,
2019
 
December 31,
2018
 
January 1,
2018
Short-term contract assets
Prepaid expenses and other current assets
 
$
26.3

 
$
25.5

 
$
20.5
Product  
Revenue from External Customer [Line Items]  
Disaggregation of revenue
We generated third-party revenue in the following geographic locations(1) during each of the periods presented below (in millions):
 
Year Ended
 
December 31,
2019
 
December 31,
2018
 
December 31,
2017
U.S.
$
3,225.6

 
$
3,098.3

 
$
3,272.3

Europe(2)
1,335.8

 
1,347.6

 
1,343.6

All other countries(3)
276.0

 
285.8

 
330.3

Total net sales
$
4,837.4

 
$
4,731.7

 
$
4,946.2


(1)    The net sales by geography is derived from the location of the entity that sells to a third party.
(2)
Includes Ireland net sales of $23.4 million, $25.7 million, and $30.4 million for the years ended December 31, 2019, December 31, 2018, and December 31, 2017, respectively.
(3) Includes revenue generated primarily in Israel, Mexico, Australia, and Canada.

    
Product Category

We re-aligned our product categories in our CSCA and CSCI segments as of December 31, 2019. The re-alignment standardizes our categories and product level detail to provide consistency. This transformative step will optimize the way in which management reports and evaluates our business.

    
The following is a summary of our revenue by category (in millions), comparative periods reflect the product category re-alignment:
 
Year Ended
 
December 31, 2019
 
December 31, 2018
 
December 31,
2017
CSCA(1)
 
 
 
 
 
Upper respiratory
$
515.2

 
$
492.5

 
$
485.4

Digestive health
413.9

 
403.6

 
411.5

Nutrition
394.4

 
432.4

 
423.6

Pain and sleep-aids
383.6

 
388.1

 
364.8

Healthy lifestyle
352.4

 
333.6

 
341.0

Skincare and personal hygiene
182.9

 
164.1

 
163.5

Oral self-care
106.4

 
—

 
—

Animal health
43.7

 
93.9

 
141.3

Vitamins, minerals, and supplements
28.6

 
26.1

 
38.0

Other CSCA(2)
66.6

 
77.3

 
60.8

Total CSCA
2,487.7

 
2,411.6

 
2,429.9

CSCI
 
 
 
 
 
Skincare and personal hygiene
371.6

 
396.5

 
401.8

Upper respiratory
276.8

 
276.5

 
270.8

Vitamins, minerals, and supplements
180.2

 
187.2

 
177.9

Healthy lifestyle
173.8

 
180.7

 
182.5

Pain and sleep-aids
167.9

 
170.0

 
150.8

Oral self-care
51.2

 
8.9

 
11.0

Digestive health
27.1

 
29.5

 
29.2

Other CSCI(3)
133.6

 
150.0

 
182.2

Total CSCI
1,382.2

 
1,399.3

 
1,406.2

RX
967.5

 
920.8

 
1,054.4

Other
—

 
—

 
55.7

Total net sales
$
4,837.4

 
$
4,731.7

 
$
4,946.2


(1)    Includes net sales from our OTC contract manufacturing business.
(2)
Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
(3)
Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.